Xenon Pharmaceuticals Other Operating Expenses (Quarterly) Analysis

Xenon Pharmaceuticals, Inc. (XENE)

41.49 +1.51 (+3.78%) USD | NASDAQ | Jan 20, 16:00

41.49 0.00 (0.00%) After-Hours: 16:47

View Other Operating Expenses (Quarterly) for XENE.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Operating Expenses (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Operating Expenses (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Operating Expenses (Quarterly) Benchmarks

Start Trial

Oncolytics Biotech, Inc.	--
Aurinia Pharmaceuticals, Inc.	Upgrade
Edesa Biotech, Inc.	Upgrade
Lexaria Bioscience Corp.	--
ProMIS Neurosciences, Inc.	--